Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Giampapa Institute for Anti-Aging Medical Therapy is a clinical facility dedicated to regenerative medicine and personalized longevity protocols. Founded by Dr. Vincent Giampapa, a pioneer in the field of anti-aging, the institute utilizes advanced diagnostics to create customized health programs for its patients. Key services include stem cell-based therapies, hormone replacement, and DNA-repair-focused nutritional strategies. The institute emphasizes a cellular approach to aging, aiming to optimize the health of stem cells and telomeres to slow biological decline. By integrating genetic testing with clinical intervention, the facility serves as a leading destination for individuals seeking to extend their healthspan through evidence-based regenerative techniques.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Giampapa Institute for Anti-Aging Medical Therapy.